Quick Answer
Zomedica Corp. reported Net Income Loss of -$81.86 million for the year ending 2025.
- Zomedica Corp. showed a decrease of -74.2% in Net Income Loss from 2024 to 2025.
- This data is from Zomedica Corp.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Zomedica Corp.'s Net Income Loss has declined by 1,326.0%.
- Historical annual values: Fiscal year 2025: -$81.86 million | Fiscal year 2024: -$46.98 million | Fiscal year 2023: -$34.53 million | Fiscal year 2022: -$17.02 million | Fiscal year 2021: -$18.38 million | Fiscal year 2020: -$16.91 million | Fiscal year 2019: -$19.78 million | Fiscal year 2018: -$16.65 million | Fiscal year 2017: -$8.07 million | Fiscal year 2016: -$5.74 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: